ArticleBioengineering (Basel, Switzerland)2026
DuDeM: A Dual-Network Model for Early Gastric Cancer Detection Based on Capsule Endoscopy.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Early detection is critical for improving outcomes in gastric cancer, yet lesion recognition in capsule endoscopy is challenged by interference from different gastric anatomical sites, patient posture changes, and gastric peristalsis. This study aims to prompt a robust deep learning model to address these challenges. A dual-network model, named DuDeM (DualNet Detection Model), was developed by integrating a ResNet50-based convolutional branch with a CapsuleNet branch incorporating dynamic routing. The convolutional branch extracts local lesion features that are transmitted to primary capsules, while dynamic routing enables adaptive matching between capsule layers to establish local-global feature associations. An attention-weighted strategy is applied for feature fusion. The model was trained using capsule endoscopy images from nine hospitals in China and public datasets, and its performance was compared with eight representative models, with ablation analyses validating key components. Results showed that DuDeM achieved an area under the curve (AUC) of 0.981 and an F1-score of 0.979, with sensitivity, specificity, and precision all exceeding 97%, and performance degradation limited to within 3% under mild image perturbations. These findings suggest that DuDeM enables reliable early gastric cancer (EGC) recognition and may support large-scale capsule endoscopy screening in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.